Oct 17 2025 This Week in Cardiology

Another knock against the antiplatelet/anticoagulant combo, polypills in HF, the physical exam of the future, and the problem of underpowered trials that even Bayesian analyses cannot rescue are the topics John Mandrola, MD, discusses in this week's podcast.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit:
https://www.medscape.com/twic
I Listener Feedback
Trends Study https://www.heartrhythmjournal.com/article/S1547-5271(11)00496-6/fulltext
II Another knock against the Antiplatelet/Anticoagulation combination
"Antiplatelet Plus Oral Anticoagulant Lowers Stroke, Raises Bleeding Risk" https://www.medscape.com/viewarticle/antiplatelet-plus-oral-anticoagulant-lowers-stroke-raises-2025a1000re0
ATIS-NVAF Trial https://jamanetwork.com/journals/jamaneurology/fullarticle/2839511
AQUATIC trial https://www.nejm.org/doi/abs/10.1056/NEJMoa2507532
III Polypill for HFrEF
A Multilevel Polypill for Patients With HFrEF https://www.jacc.org/doi/10.1016/j.jacadv.2025.102195
IV The Physical Exam of the Future
Point-of-Care Ultrasound https://doi.org/10.1016/j.jchf.2025.102707
V More on Underpowered Trials – GA vs Moderate Sedation in IV stroke
SEGA Trial https://jamanetwork.com/journals/jamaneurology/fullarticle/2839838
Bayesian Analyses of CV Trials https://doi.org/10.1016/j.cjca.2021.03.014
You may also like:
The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact [email protected]
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.